Lupin Dental, a French dental robotics company, has closed a €15 million Series A financing round to support the scaling and commercialisation of its robotic platform for minimally invasive dental procedures.
The funding round was led by Fynveur, with participation from Bpifrance, Invus, existing shareholders, and private investors. The capital injection represents a significant milestone for the Montpellier-based startup, which was founded in 2019 and has now raised €15 million in total funding.
Expanding Market Presence
Lupin Dental plans to deploy the Series A proceeds across several strategic initiatives. The company intends to expand its partnerships with academic and medical institutions as well as dental professionals, while simultaneously accelerating product development and commercialisation efforts. The funding will also support widespread adoption of its robotic technology across dental practices.
The startup’s robotic system represents an evolution in dental care delivery, targeting procedures that traditionally require manual intervention. By introducing robotics to dental surgery, Lupin Dental aims to enhance precision and reduce patient trauma during treatment.
“Lupin Dental opens a new chapter with this important milestone. It reflects our investors’ confidence in our vision and enables us to accelerate our mission to transform dental care through innovation,” said Dr. Galip Gürel and Dr. Stefen Koubi, the company’s leadership.
Growing European Dental Robotics Interest
The funding underscores growing investor interest in healthcare automation across Europe, particularly in dental technology. Dental robotics remains an emerging segment within the broader healthtech landscape, with potential applications ranging from implant placement to prosthetics and surgical interventions. The sector has attracted increasing attention from venture capital firms seeking exposure to healthcare innovation and procedural efficiency gains.
Fynveur’s lead investment role signals confidence in the company’s business model and market opportunity. The venture capital firm’s backing joins the support of Bpifrance, France’s public investment bank, which has prioritised deeptech and healthtech sectors as strategic priorities for French innovation.
The participation of Invus, alongside other investors, reflects broader institutional confidence in Lupin Dental’s technology and management team. The combination of public and private capital typically indicates strong belief in both the commercial potential and the technological soundness of the platform.
The capital raise positions Lupin Dental to compete in an increasingly competitive dental technology market, where automation and precision are becoming differentiating factors. As European healthcare systems grapple with efficiency challenges and cost pressures, robotic solutions in dental care could offer pathways to improved outcomes and streamlined operations.
The company’s growth trajectory reflects a wider European trend of applying robotics and artificial intelligence to healthcare specialties traditionally dependent on manual procedures. With this fresh capital, Lupin Dental is positioned to validate its technology in clinical settings and establish market presence across European dental markets.